Michelle McMurry-Heath, BIO CEO (BIO)

BIO and a string of CEOs is­sue a call for FDA in­de­pen­dence and against sci­ence-by-press-re­lease

It ap­pears to be open let­ter week in biotech.

On Sun­day, Scripps Re­search’s Er­ic Topol penned a scathing let­ter in Med­scape call­ing for FDA com­mis­sion­er Stephen Hahn to re­sign af­ter a se­ries of al­leged mis­steps and po­lit­i­cal con­ces­sions.  And to­day, in a care­ful­ly-word­ed piece, the head of BIO and eight well-known biotech CEOs is­sued a call for the FDA’s in­de­pen­dence and for biotechs — with the world spot­light on them — to be on their best be­hav­ior.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.